With our innovative techniques and many years of experience, Creative Biolabs can provide CellRapeutics™ bispecific Chimeric Antigen Receptors (CARs) construction service.
Creative Biolabs can not only offer regular CAR construction service but also generate engineered T cells or NK cells with bispecific CAR, strategy which has two different types of CARs engrafted in T cells, to enable these T cells with the ability of inhibiting activation or increasing the specificity of T cells. The second CAR can be either completely independent of the first one, or a tandem scFv just fused with the first CAR, both of these approaches are used to redirect immune cells and amplify the specificity signal of CAR-T cells. In some cases, the second CAR can bind an antigen different from the target of the first one and subsequently inhibit the signal domain of the first CAR, which can enhance the specificity of T cells and greatly facilitate adoptive T cell immunotherapy.
Therefore, our bispecific CAR technology platform offers you the best choice for your cancer therapy research.
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved